123 related articles for article (PubMed ID: 10886304)
1. Low levels of colonic glutathione S-transferase in patients with X-linked agammaglobulinaemia.
Grubben MJ; van den Braak CC; Peters WH; van der Meer JW; Nagengast FM
Eur J Clin Invest; 2000 Jul; 30(7):642-5. PubMed ID: 10886304
[TBL] [Abstract][Full Text] [Related]
2. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in patients with X-linked agammaglobulinaemia.
van der Meer JW; Weening RS; Schellekens PT; van Munster IP; Nagengast FM
Lancet; 1993 Jun; 341(8858):1439-40. PubMed ID: 8099142
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-S-transferase pi expression and activity is increased in colonic neoplasia.
Naidu KA; Nasir A; Pinkas H; Kaiser HE; Brady P; Coppola D
In Vivo; 2003; 17(5):479-82. PubMed ID: 14598612
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.
Szarka CE; Pfeiffer GR; Hum ST; Everley LC; Balshem AM; Moore DF; Litwin S; Goosenberg EB; Frucht H; Engstrom PF
Cancer Res; 1995 Jul; 55(13):2789-93. PubMed ID: 7796404
[TBL] [Abstract][Full Text] [Related]
6. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age.
Hoensch H; Peters WH; Roelofs HM; Kirch W
Curr Med Res Opin; 2006 Jun; 22(6):1075-83. PubMed ID: 16846540
[TBL] [Abstract][Full Text] [Related]
7. Glutathione concentrations and glutathione S-transferase activity in human colonic neoplasms.
Butler RN; Butler WJ; Moraby Z; Fettman MJ; Khoo KK; Roberts-Thomson IC
J Gastroenterol Hepatol; 1994; 9(1):60-3. PubMed ID: 8155868
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferases in liver metastases of colorectal cancer. A comparison with normal liver and primary carcinomas.
Mulder TP; Roelofs HM; Peters WH; Wagenmans MJ; Sier CF; Verspaget HW
Carcinogenesis; 1994 Oct; 15(10):2149-53. PubMed ID: 7955047
[TBL] [Abstract][Full Text] [Related]
9. Disparities of conjugating protective enzyme activities in the colon of patients with adenomas and carcinomas.
Hoensch HP; Roelofs HM; Edler L; Kirch W; Peters WH
World J Gastroenterol; 2013 Sep; 19(36):6020-5. PubMed ID: 24106402
[TBL] [Abstract][Full Text] [Related]
10. The glutathione biotransformation system and colorectal cancer risk in humans.
Grubben MJ; Nagengast FM; Katan MB; Peters WH
Scand J Gastroenterol Suppl; 2001; (234):68-76. PubMed ID: 11768564
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid.
Nobuoka A; Takayama T; Miyanishi K; Sato T; Takanashi K; Hayashi T; Kukitsu T; Sato Y; Takahashi M; Okamoto T; Matsunaga T; Kato J; Oda M; Azuma T; Niitsu Y
Gastroenterology; 2004 Aug; 127(2):428-43. PubMed ID: 15300575
[TBL] [Abstract][Full Text] [Related]
12. Large-bowel mucosal biotransformation activity in persons at high risk for colorectal cancer. A preliminary report.
Tobi M; Darmon E; Rozen P; Avigdor S; Rattan J; Santo M; Barnea ER
Scand J Gastroenterol; 1993 Nov; 28(11):958-62. PubMed ID: 8284630
[TBL] [Abstract][Full Text] [Related]
13. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
14. Telomere length in the colon is related to colorectal adenoma prevalence.
Peacock SD; Massey TE; Vanner SJ; King WD
PLoS One; 2018; 13(10):e0205697. PubMed ID: 30332457
[TBL] [Abstract][Full Text] [Related]
15. Detection of telomerase activity in biopsy samples of colorectal cancer.
Fang DC; Young J; Luo YH; Lu R; Jass J
J Gastroenterol Hepatol; 1999 Apr; 14(4):328-32. PubMed ID: 10207781
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferases activity in patients with colorectal cancer.
Nomani H; Ghobadloo SM; Yaghmaei B; Rezvanie NA; Yaghmaei K
Clin Biochem; 2005 Jul; 38(7):621-4. PubMed ID: 15904910
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase polymorphisms and risk of colorectal adenomas.
Inoue H; Kiyohara C; Shinomiya S; Marugame T; Tsuji E; Handa K; Hayabuchi H; Eguchi H; Fukushima Y; Kono S
Cancer Lett; 2001 Feb; 163(2):201-6. PubMed ID: 11165755
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis.
Miyanishi K; Takayama T; Ohi M; Hayashi T; Nobuoka A; Nakajima T; Takimoto R; Kogawa K; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Oct; 121(4):865-74. PubMed ID: 11606500
[TBL] [Abstract][Full Text] [Related]
19. Xenobiotic metabolising enzyme expression in colonic neoplasia.
McKay JA; Murray GI; Weaver RJ; Ewen SW; Melvin WT; Burke MD
Gut; 1993 Sep; 34(9):1234-9. PubMed ID: 8406161
[TBL] [Abstract][Full Text] [Related]
20. Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa.
Mörk H; al-Taie OH; Bähr K; Zierer A; Beck C; Scheurlen M; Jakob F; Köhrle J
Nutr Cancer; 2000; 37(1):108-16. PubMed ID: 10965527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
